Oarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element

Cancer Research

Volumn 61, Issue 4, 2001, Pages 1291-1295

  Selvakumaran, Muthu ^a   Bao, Rudi ^a   Crijns, Anne P G ^a,b   Connolly, Denise C ^a   Weinstein, Jillian K ^a   Hamilton, Thomas C ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOVENE IV; GANCICLOVIR; THYMIDINE KINASE; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DRUG EFFICACY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RETROVIRUS; RUGBY; SCID MOUSE; SEQUENCE ANALYSIS; TRANSGENIC MOUSE; ANIMAL; BIOTRANSFORMATION; CELL CULTURE; COMPARATIVE STUDY; DRUG SCREENING; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; RAT; RETROPOSON; TRANSACTIVATION;

ANIMALS; BASE SEQUENCE; BIOTRANSFORMATION; CELL LINEAGE; EPITHELIAL CELLS; FEMALE; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, REPORTER; HUMANS; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PRODRUGS; PROMOTER REGIONS (GENETICS); RATS; RETROELEMENTS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035864369     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. The biology of ovarian cancer
2. Chemotherapy of ovarian cancer
3. Mechanisms of drug resistance in ovarian cancer
4. Gene therapy for Ovarian carcinoma
5. Use of a tissue-specific promoter for targeted expression of herpes simplex virus thymidine kinase gene in cervical carcinoma cells
6. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus
7. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virusthymidine kinase gene
8. Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter
9. Tissue specific promoters in targeting systemically delivered gene therapy
10. Retrovirus-mediated suicide gene/prodrug therapy targeting thyroid carcinoma using a thyroid-specific promoter
11. Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells
12. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines
13. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer
14. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells
15. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines
16. Matlnd and Matinspector-new fast and versatile tools for detection of consensus matches in nucleotide sequence data
17. CCAAT enhancer-binding protein β and GATA-4 binding regions within the promoter of the steroidogenic acute regulatory protein (StAR) gene are required for transcription in rat ovarian cells
18. Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice